PharmaCyte Biotech (PMCB) Short Interest Ratio & Short Volume → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free PMCB Stock Alerts $2.15 -0.02 (-0.92%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsOptions ChainOwnershipSEC FilingsShort InterestSocial Media PharmaCyte Biotech Short Interest DataCurrent Short Volume13,000 sharesPrevious Short Volume18,200 sharesChange Vs. Previous Month-28.57%Dollar Volume Sold Short$27,560.00Short Interest Ratio / Days to Cover0.5Last Record DateApril 30, 2024Outstanding Shares8,450,000 sharesFloat Size7,610,000 sharesShort Percent of Float0.17%Today's Trading Volume6,810 sharesAverage Trading Volume10,181 sharesToday's Volume Vs. Average67% Short Selling PharmaCyte Biotech ? Sign up to receive the latest short interest report for PharmaCyte Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPMCB Short Interest Over TimePMCB Days to Cover Over TimePMCB Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here PharmaCyte Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202413,000 shares $27,560.00 -28.6%0.2%0.5 $2.12 4/15/202418,200 shares $38,402.00 -60.2%0.2%0.7 $2.11 3/31/202445,700 shares $108,309.00 +501.3%0.6%1.8 $2.37 3/15/20247,600 shares $14,820.00 -68.7%0.1%0.3 $1.95 2/29/202424,300 shares $51,030.00 -4.3%0.3%1.6 $2.10 2/15/202425,400 shares $53,086.00 -19.4%0.4%1.6 $2.09 Get the Latest News and Ratings for PMCB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter. 1/31/202431,500 shares $68,985.00 +18.9%0.4%2 $2.19 1/15/202426,500 shares $59,625.00 -14.8%0.4%1.5 $2.25 12/31/202331,100 shares $67,176.00 +15.2%0.5%1.8 $2.16 12/15/202327,000 shares $58,050.00 +2.7%0.4%1.5 $2.15 11/30/202326,300 shares $59,438.00 -9.6%0.4%1.4 $2.26 11/15/202329,100 shares $59,364.00 -12.6%0.4%1.5 $2.04 10/31/202333,300 shares $70,596.00 -17.4%0.5%1.6 $2.12 10/15/202340,300 shares $84,227.00 -12.2%0.6%1.9 $2.09 9/30/202345,900 shares $96,390.00 -27.8%0.7%2.1 $2.10 9/15/202363,600 shares $159,000.00 +27.0%0.9%3 $2.50 8/31/202350,100 shares $122,745.00 -4.0%0.6%1.9 $2.45 6/30/202139,300 shares $424.44 +48.9%N/A0 $0.01 6/15/202126,400 shares $298.32 -27.7%N/A0 $0.01 5/28/202136,500 shares $463.55 -69.0%N/A0 $0.01 5/14/2021117,600 shares $1,481.76 +113.4%N/A0 $0.01 4/30/202155,100 shares $936.70 -72.2%N/A0 $0.02 4/15/2021198,000 shares $3,245.22 +11.1%N/A0 $0.02 3/31/2021178,200 shares $3,073.95 +11.0%N/A0 $0.02 3/15/2021160,500 shares $3,370.50 +817.1%N/A0 $0.02 2/26/202117,500 shares $507.50 -93.3%N/A0 $0.03 2/12/2021260,800 shares $4,824.80 +327.5%N/A0 $0.02 1/29/202161,000 shares $1,037.00 +42.9%N/A0 $0.02 1/15/202128,200 shares $383.52 -69.7%N/A0 $0.01 12/31/202041,700 shares $271.05 +47.9%N/A0 $0.01 12/15/202028,200 shares $155.10 -69.7%N/A0 $0.01 11/30/202093,200 shares $559.20 +486.2%N/A0 $0.01 11/15/202015,900 shares $108.12 No ChangeN/A0 $0.01 10/30/202015,900 shares $141.51 +13.6%N/A0 $0.01 10/15/202014,000 shares $131.60 -74.0%N/A0 $0.01 9/30/202053,900 shares $916.30 +20.0%N/A0 $0.02 9/15/202044,900 shares $493.90 -58.9%N/A0 $0.01 8/31/2020109,300 shares $1,300.67 +680.7%N/A0 $0.01 8/14/202014,000 shares $196.00 -95.6%N/A0 $0.01 7/31/2020319,600 shares $4,474.40 +413.0%N/A0 $0.01Gold Set to EXPLODE! (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! PMCB Short Interest - Frequently Asked Questions What is PharmaCyte Biotech's current short interest? Short interest is the volume of PharmaCyte Biotech shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 13,000 shares of PMCB short. 0.17% of PharmaCyte Biotech's shares are currently sold short. Learn More on PharmaCyte Biotech's current short interest. What is a good short interest percentage for PharmaCyte Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.17% of PharmaCyte Biotech's floating shares are currently sold short. Is PharmaCyte Biotech's short interest increasing or decreasing? PharmaCyte Biotech saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 13,000 shares, a drop of 28.6% from the previous total of 18,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is PharmaCyte Biotech's float size? PharmaCyte Biotech currently has issued a total of 8,450,000 shares. Some of PharmaCyte Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. PharmaCyte Biotech currently has a public float of 7,610,000 shares. How does PharmaCyte Biotech's short interest compare to its competitors? 0.17% of PharmaCyte Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to PharmaCyte Biotech: Senti Biosciences, Inc. (1.05%), Aptose Biosciences Inc. (0.86%), Evaxion Biotech A/S (1.02%), ZIVO Bioscience, Inc. (4.24%), Coeptis Therapeutics Holdings, Inc. (0.57%), Genetic Technologies Limited (0.58%), Brainstorm Cell Therapeutics Inc. (3.07%), BioCardia, Inc. (0.98%), Organovo Holdings, Inc. (4.09%), Palisade Bio, Inc. (21.34%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short PharmaCyte Biotech stock? Short selling PMCB is an investing strategy that aims to generate trading profit from PharmaCyte Biotech as its price is falling. PMCB shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PharmaCyte Biotech? A short squeeze for PharmaCyte Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PMCB, which in turn drives the price of the stock up even further. How often is PharmaCyte Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PMCB, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Senti Biosciences Short Squeeze Aptose Biosciences Short Squeeze Evaxion Biotech A/S Short Squeeze ZIVO Bioscience Short Squeeze Coeptis Therapeutics Short Squeeze Genetic Technologies Short Squeeze Brainstorm Cell Therapeutics Short Squeeze BioCardia Short Squeeze Organovo Short Squeeze Palisade Bio Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PMCB) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldGold Set to EXPLODE!Gold Safe Exchange[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsElon to Transform U.S. Economy? Porter & Company